Loughborough University
Browse

Supplementary Information Files for Mechanical loading of tissue engineered skeletal muscle prevents dexamethasone induced myotube atrophy

Download (21.3 kB)
dataset
posted on 2021-08-13, 12:50 authored by Kathryn Aguilar-Agon, Andrew CapelAndrew Capel, Jacob Fleming, Darren J. Player, Neil MartinNeil Martin, Mark LewisMark Lewis
Supplementary Information Files for Mechanical loading of tissue engineered skeletal muscle prevents dexamethasone induced myotube atrophy
Skeletal muscle atrophy as a consequence of acute and chronic illness, immobilisation, muscular dystrophies and aging, leads to severe muscle weakness, inactivity and increased mortality. Mechanical loading is thought to be the primary driver for skeletal muscle hypertrophy, however the extent to which mechanical loading can offset muscle catabolism has not been thoroughly explored. In vitro 3D-models of skeletal muscle provide a controllable, high throughput environment and mitigating many of the ethical and methodological constraints present during in vivo experimentation. This work aimed to determine if mechanical loading would offset dexamethasone (DEX) induced skeletal muscle atrophy, in muscle engineered using the C2C12 murine cell line. Mechanical loading successfully offset myotube atrophy and functional degeneration associated with DEX regardless of whether the loading occurred before or after 24 h of DEX treatment. Furthermore, mechanical load prevented increases in MuRF-1 and MAFbx mRNA expression, critical regulators of muscle atrophy. Overall, we demonstrate the application of tissue engineered muscle to study skeletal muscle health and disease, offering great potential for future use to better understand treatment modalities for skeletal muscle atrophy.

History

School

  • Sport, Exercise and Health Sciences

Usage metrics

    Sport, Exercise and Health Sciences

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC